EQT has cleared its Q2 print and the immediate reaction tells a familiar story — analysts nudging targets higher, shorts remaining thin, and peers outrunning the stock on the week.
The most notable post-earnings development is on the analyst desk. Two firms raised targets on July 22 itself. Barclays lifted to $70 from $69, maintaining Overweight. Stephens moved to $72 from $71, also keeping its positive rating. That reverses the weeks of quiet target-trimming documented in prior notes — Morgan Stanley had cut to $68 from $74 in late June, and UBS and Jefferies had also shaved their numbers through early July. The Street's consensus remains constructively bullish, with the mean target at $67.88 implying roughly 36% upside from the current $49.80 print. All four hold ratings in the dataset are the only dissent from an otherwise buy-heavy register. Bulls point to rising natural gas demand from data centers and LNG exports, plus EQT's scale in the Appalachian Basin and disciplined cost structure. Bears flag the leverage, geographic concentration, and the ever-present commodity price risk — and note that strong execution in the core Marcellus program is not optional for the thesis to work.
Positioning remains as undemanding as it has been all month. Short interest dropped nearly 4% on July 21 to 21.5 million shares, or 3.4% of the free float — the lowest reading in the 30-day window and a continuation of the gradual unwind flagged in previous notes. Borrow availability is extraordinarily loose at over 2,600%, meaning more than twenty-six shares are available in the lending pool for every one currently borrowed. Cost to borrow has ticked up 22% on the week to 0.42%, but that remains a trivially low friction cost — well within the range it has traded all month. The ORTEX short score has eased to 35.8, its lowest level in the recent window, reinforcing that bears are stepping further back rather than pressing into the print. Options are slightly more guarded than usual — the put/call ratio moved up to 0.895 on July 21, above its 20-day average of 0.850 and a z-score of 0.62 — but that is a modest uptick rather than a directional signal. Overall, the lending and options markets are consistent: positioning is quiet, not charged.
Where EQT looks less comfortable is relative performance. The stock gained 1.5% on July 21 but is essentially flat on the week, down less than 0.1%. Close peers have done considerably better. RRC gained 3.5% on the week and 2.9% on the day. CNX is up nearly 4% on the week. NOG has added almost 9% over the same period. Even CRK and BKV are running 2-3% ahead of EQT on the week. The ORTEX momentum score reflects this — relative strength across the 91-, 182-, and 365-day windows is negative, and momentum ranks as the weakest pillar in EQT's composite stock score. The growth and quality fundamentals are sound, but the price action has lagged the cohort for long enough to register as a pattern rather than noise.
Institutional holders at least are not pressing the exit button. BlackRock added 7.6 million shares in the period to end-June, bringing its stake to 9.75% of shares outstanding. State Street added 3.1 million shares and T. Rowe Price added 5.2 million over the same window. That concentration of incremental buying among large passive and active managers provides a natural demand floor, even as the stock underperforms peers. CEO Toby Rice sold roughly $5.3 million worth of shares in early June at prices between $53 and $55 — well above the current $49.80 — a move that carried low trade significance scores and looks more like scheduled liquidation than a read on near-term direction.
The next scheduled earnings event is October 20. Between now and then, the question worth tracking is whether the post-print analyst target lifts — modest as they are — translate into any relative momentum recovery, or whether EQT continues to lag peers in a tape where natural gas names are broadly firmer.
See the live data behind this article on ORTEX.
Open EQT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
